Hypoxia-Inducible Factor-1α in Smooth Muscle Cells Protects Against Aortic Aneurysms—Brief Report

Author:

Imanishi Masaki1,Chiba Yoichi1,Tomita Noriko1,Matsunaga Shinji1,Nakagawa Toshitaka1,Ueno Masaki1,Yamamoto Kazuhiro1,Tamaki Toshiaki1,Tomita Shuhei1

Affiliation:

1. From the Division of Molecular Pharmacology, Faculty of Medicine, Tottori University, Japan (M.I., S.M., S.T.); Department of Pathology and Host Defense, Faculty of Medicine, Kagawa University, Japan (Y.C., M.U.); Division of Molecular Medicine and Therapeutics, Faculty of Medicine, Tottori University, Japan (N.T., K.Y.); Life Science Research Center, Kagawa University, Japan (T.N.); Department of Pharmacology, Institute of Biomedical Sciences, Tokushima University Graduate School, Japan (T.T.); and...

Abstract

Objective— The purpose of this study was to determine the role of smooth muscle cell–derived hypoxia-inducible factor-1α (Hif-1α) in the pathogenesis of aortic aneurysms. Approach and Results— Control mice and smooth muscle cell–specific hypoxia-inducible factor-1α–deficient mice were infused with β-aminopropionitrile for 2 weeks and angiotensin II for 6 weeks to induce aortic aneurysm formation. Mutant mice experienced increased levels of aneurysm formation of the thoracic or abdominal aorta with more severe elastin disruption, compared with control mice. Smooth muscle cell–specific hypoxia-inducible factor-1α deficiency did not affect matrix metalloproteinase-2 activity; however, the activity of lysyl oxidase and the levels of tropoelastin mRNA in the angiotensin II– and β-aminopropionitrile–treated aortae, associated with elastin fiber formation, were suppressed. Furthermore, we observed reduced volumes of mature cross-linked elastin in the thoracoabdominal aorta after treatment with angiotensin II and β-aminopropionitrile. Conclusions— Deficiency of smooth muscle cell–derived hypoxia-inducible factor-1α augments aortic aneurysms, accompanied by disruption of elastin fiber formation, but not changes of elastin fiber degradation.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3